Corvus Pharmaceuticals, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Corvus Pharmaceuticals, Inc. (CRVS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $2.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $2.19M, a 91.42% increase year-over-year.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $499.00K, a 241.78% increase year-over-year.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $765.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $708.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $2.76M.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$245.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$3.58M, a 866.17% decline from fiscal 2022.
- Corvus Pharmaceuticals, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $467.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 11 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.69M 10-Q · filed 2026-08-06 | $3.45M derived: sum of 3 quarters · filed 2026-08-06 | $4.16M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $499.00K 10-Q · filed 2026-05-07 | $1.26M derived: sum of 2 quarters · filed 2026-05-07 | $1.97M derived: sum of 3 quarters · filed 2026-05-07 | $3.11M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.47M derived: sum of 2 quarters · filed 2026-03-12 | $2.62M derived: sum of 3 quarters · filed 2026-08-06 | $2.76M 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | $708.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.85M derived: sum of 2 quarters · filed 2026-08-06 | $2.00M 10-Q · filed 2025-11-04 | $1.51M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.29M 10-Q · filed 2026-08-06 | $798.00K derived: sum of 3 quarters · filed 2026-08-06 | $709.00K derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $146.00K 10-Q · filed 2026-05-07 | -$344.00K derived: sum of 2 quarters · filed 2026-05-07 | -$433.00K derived: sum of 3 quarters · filed 2026-05-07 | -$200.00K derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | -$490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$579.00K derived: sum of 2 quarters · filed 2026-03-12 | -$346.00K derived: sum of 3 quarters · filed 2026-03-12 | -$245.00K 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $144.00K derived: sum of 2 quarters · filed 2025-11-04 | $245.00K 10-Q · filed 2025-11-04 | -$344.00K derived: sum of 4 quarters · filed 2026-03-12 | |||||
| 2024-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $334.00K 10-Q · filed 2025-08-07 | -$255.00K derived: sum of 3 quarters · filed 2026-03-12 | -$157.00K derived: sum of 4 quarters · filed 2026-03-12 | |||||
| 2024-03-31 | $101.00K 10-Q · filed 2025-05-08 | -$488.00K derived: sum of 2 quarters · filed 2026-03-12 | -$390.00K derived: sum of 3 quarters · filed 2026-03-12 | -$1.55M derived: sum of 4 quarters · filed 2026-03-12 | |||||
| 2023-12-31 | -$589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$491.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.65M derived: sum of 3 quarters · filed 2026-03-12 | -$3.58M 10-K · filed 2026-03-12 | |||||
| 2023-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.06M derived: sum of 2 quarters · filed 2024-11-12 | -$2.99M 10-Q · filed 2024-11-12 | -$4.01M derived: sum of 4 quarters · filed 2025-03-25 | |||||
| 2023-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$3.09M 10-Q · filed 2024-08-06 | -$4.11M derived: sum of 3 quarters · filed 2025-03-25 | -$1.91M derived: sum of 4 quarters · filed 2025-03-25 | |||||
| 2023-03-31 | -$1.93M 10-Q · filed 2024-05-07 | -$2.95M derived: sum of 2 quarters · filed 2025-03-25 | -$751.00K derived: sum of 3 quarters · filed 2025-03-25 | -$366.00K derived: sum of 4 quarters · filed 2025-03-25 | |||||
| 2022-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.18M derived: sum of 2 quarters · filed 2025-03-25 | $1.56M derived: sum of 3 quarters · filed 2025-03-25 | $467.00K 10-K · filed 2025-03-25 | |||||
| 2022-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.58M derived: sum of 2 quarters · filed 2023-11-07 | $1.49M 10-Q · filed 2023-11-07 | $614.00K derived: sum of 4 quarters · filed 2024-03-19 | |||||
| 2022-06-30 | $385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$710.00K 10-Q · filed 2023-08-08 | -$1.58M derived: sum of 3 quarters · filed 2024-03-19 | -$1.97M derived: sum of 4 quarters · filed 2024-03-19 | |||||
| 2022-03-31 | -$1.09M 10-Q · filed 2023-05-08 | -$1.97M derived: sum of 2 quarters · filed 2024-03-19 | -$2.36M derived: sum of 3 quarters · filed 2024-03-19 | -$1.91M derived: sum of 4 quarters · filed 2024-03-19 | |||||
| 2021-12-31 | -$875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$1.26M derived: sum of 2 quarters · filed 2024-03-19 | -$810.00K derived: sum of 3 quarters · filed 2024-03-19 | -$523.00K 10-K · filed 2024-03-19 | |||||
| 2021-09-30 | -$386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $65.00K derived: sum of 2 quarters · filed 2022-11-03 | $352.00K 10-Q · filed 2022-11-03 | -$448.00K derived: sum of 4 quarters · filed 2023-03-28 | |||||
| 2021-06-30 | $451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $738.00K 10-Q · filed 2022-08-08 | -$62.00K derived: sum of 3 quarters · filed 2023-03-28 | $544.00K derived: sum of 4 quarters · filed 2023-03-28 | |||||
| 2021-03-31 | $287.00K 10-Q · filed 2022-05-05 | -$513.00K derived: sum of 2 quarters · filed 2023-03-28 | $93.00K derived: sum of 3 quarters · filed 2023-03-28 | $462.00K derived: sum of 4 quarters · filed 2023-03-28 | |||||
| 2020-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$194.00K derived: sum of 2 quarters · filed 2023-03-28 | $175.00K derived: sum of 3 quarters · filed 2023-03-28 | $705.00K 10-K · filed 2023-03-28 | |||||
| 2020-09-30 | $606.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $975.00K derived: sum of 2 quarters · filed 2021-11-01 | $1.50M 10-Q · filed 2021-11-01 | $1.64M derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2020-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $899.00K 10-Q · filed 2021-08-02 | $1.04M derived: sum of 3 quarters · filed 2022-03-10 | $557.00K derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2020-03-31 | $530.00K 10-Q · filed 2021-04-29 | $669.00K derived: sum of 2 quarters · filed 2022-03-10 | $188.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.86M derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2019-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$342.00K derived: sum of 2 quarters · filed 2022-03-10 | $1.33M derived: sum of 3 quarters · filed 2022-03-10 | $2.04M 10-K · filed 2022-03-10 | $2.03M 10-K · filed 2020-03-09 | ||||
| 2019-09-30 | -$481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.19M derived: sum of 2 quarters · filed 2020-10-29 | $1.90M 10-Q · filed 2020-10-29 | $1.73M 10-Q · filed 2019-10-29 | $988.00K derived: sum of 4 quarters · filed 2021-03-25 | ||||
| 2019-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.38M 10-Q · filed 2020-07-30 | $2.21M 10-Q · filed 2019-08-01 | $1.47M derived: sum of 3 quarters · filed 2021-03-25 | -$191.00K derived: sum of 4 quarters · filed 2021-03-25 | ||||
| 2019-03-31 | $714.00K 10-Q · filed 2020-04-30 | $555.00K 10-Q · filed 2019-05-09 | -$201.00K derived: sum of 2 quarters · filed 2021-03-25 | -$1.86M derived: sum of 3 quarters · filed 2021-03-25 | -$1.44M derived: sum of 4 quarters · filed 2021-03-25 | ||||
| 2018-12-31 | -$915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$2.58M derived: sum of 2 quarters · filed 2021-03-25 | -$2.16M derived: sum of 3 quarters · filed 2021-03-25 | -$560.00K 10-K · filed 2021-03-25 | -$458.00K 10-K · filed 2019-03-07 | ||||
| 2018-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$1.24M derived: sum of 2 quarters · filed 2019-10-29 | $355.00K 10-Q · filed 2019-10-29 | -$521.00K derived: sum of 4 quarters · filed 2020-03-09 | |||||
| 2018-06-30 | $418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.02M 10-Q · filed 2019-08-01 | $1.14M derived: sum of 3 quarters · filed 2020-03-09 | $2.16M derived: sum of 4 quarters · filed 2020-03-09 | |||||
| 2018-03-31 | $1.60M 10-Q · filed 2019-05-09 | $721.00K derived: sum of 2 quarters · filed 2020-03-09 | $1.75M derived: sum of 3 quarters · filed 2020-03-09 | $1.98M derived: sum of 4 quarters · filed 2020-03-09 | |||||
| 2017-12-31 | -$876.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $149.00K derived: sum of 2 quarters · filed 2020-03-09 | $378.00K derived: sum of 3 quarters · filed 2020-03-09 | $1.50M 10-K · filed 2020-03-09 | |||||
| 2017-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.25M derived: sum of 2 quarters · filed 2018-11-01 | $2.38M 10-Q · filed 2018-11-01 | $3.38M derived: sum of 4 quarters · filed 2019-03-07 | |||||
| 2017-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.35M 10-Q · filed 2018-08-02 | $2.36M derived: sum of 3 quarters · filed 2019-03-07 | $3.24M derived: sum of 4 quarters · filed 2019-03-07 | |||||
| 2017-03-31 | $1.12M 10-Q · filed 2018-05-03 | $2.13M derived: sum of 2 quarters · filed 2019-03-07 | $3.02M derived: sum of 3 quarters · filed 2019-03-07 | $3.32M derived: sum of 4 quarters · filed 2019-03-07 | |||||
| 2016-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.89M derived: sum of 2 quarters · filed 2019-03-07 | $2.20M derived: sum of 3 quarters · filed 2019-03-07 | $2.81M 10-K · filed 2019-03-07 | |||||
| 2016-09-30 | $888.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.19M derived: sum of 2 quarters · filed 2017-11-02 | $1.81M 10-Q · filed 2017-11-02 | $2.88M derived: sum of 4 quarters · filed 2018-03-01 | |||||
| 2016-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $920.00K 10-Q · filed 2017-08-03 | $2.00M derived: sum of 3 quarters · filed 2018-03-01 | $1.78M derived: sum of 4 quarters · filed 2018-03-01 | |||||
| 2016-03-31 | $618.00K 10-Q · filed 2017-05-04 | $1.69M derived: sum of 2 quarters · filed 2018-03-01 | $1.48M derived: sum of 3 quarters · filed 2018-03-01 | $1.76M derived: sum of 4 quarters · filed 2018-03-01 | |||||
| 2015-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $862.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.14M derived: sum of 3 quarters · filed 2018-03-01 | $1.22M 10-K · filed 2018-03-01 | |||||
| 2015-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $67.00K derived: sum of 2 quarters · filed 2016-11-03 | $142.00K 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | $281.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $356.00K 10-Q · filed 2016-08-04 | |||||||
| 2015-03-31 | $75.00K 10-Q · filed 2016-05-05 | ||||||||
| 2014-12-31 | $17.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |